Active	Status	Sponsor type	Region	Phase	Filter
12 Active 0 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
McCullars, Melissa
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Recruiting	2	288	US	CIN-102 Dose 15mg or 10mg, Placebo	CinDome Pharma, Inc.	Diabetic Gastroparesis	09/25	09/25
ECLIPSE, NCT04136002: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode	Active, not recruiting	N/A	44467	US		Guardant Health, Inc., Premier Research Group plc	Colorectal Cancer	03/24	12/25
NCT03789162: Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast	Active, not recruiting	N/A	1500	Canada, US		Exact Sciences Corporation	Colorectal Cancer	04/25	04/25
Torneden, Jill
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Recruiting	2	288	US	CIN-102 Dose 15mg or 10mg, Placebo	CinDome Pharma, Inc.	Diabetic Gastroparesis	09/25	09/25
EvolvE, NCT05774184 / 2022-001786-12: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis	Recruiting	2	75	Europe, Canada, US, RoW	barzolvolimab, Matching Placebo	Celldex Therapeutics, Celldex Therapeutics, Inc.	Eosinophilic Esophagitis	03/25	08/25
NCT05609253: Itraconazole to Prevent Recurrent Barrett's Esophagus	Active, not recruiting	1	10	US	Itraconazole in capsule form, Itraconazole in solution form	University of Kansas Medical Center, University of Texas, Southwestern Medical Center at Dallas	Barrett Oesophagitis With Dysplasia	02/24	06/25
PRECEDE, NCT04970056: Pancreatic Cancer Early Detection Consortium	Recruiting	N/A	10000	Europe, Canada, US, RoW		Arbor Research Collaborative for Health	Pancreas Cancer, Pancreas Cyst, Pancreatic Ductal Adenocarcinoma, Genetic Predisposition	12/30	12/30
Pham, Kelly
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Recruiting	2	288	US	CIN-102 Dose 15mg or 10mg, Placebo	CinDome Pharma, Inc.	Diabetic Gastroparesis	09/25	09/25
Roeder, Susie
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Recruiting	2	288	US	CIN-102 Dose 15mg or 10mg, Placebo	CinDome Pharma, Inc.	Diabetic Gastroparesis	09/25	09/25
Perdue, Amy
NCT05832151: A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Recruiting	2	288	US	CIN-102 Dose 15mg or 10mg, Placebo	CinDome Pharma, Inc.	Diabetic Gastroparesis	09/25	09/25
EXPEDITE, NCT06560307: Study of Enhanced Programming Stimulation with the Enterra® Therapy System	Recruiting	N/A	50	US	Enterra Therapy System, Gastric electrical stimulation	Enterra Medical, Inc.	Gastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus	10/26	12/26
NAVIGATE, NCT06464926: Chronic Nausea and Vomiting in Patients with Normal Gastric Emptying Using the Enterra® Therapy System	Recruiting	N/A	148	US	Enterra Therapy System	Enterra Medical, Inc., Bright Research Partners	Nausea, Vomiting	01/27	12/27